Cladribine Based Salvage Chemotherapy
A Phase II Study of the Efficacy and Pharmacogenomics of Cladribine-based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 90 patients (estimated)
- Sponsors
- Medical College of Wisconsin
- Tags
- Chemotherapy, Steroid
- Trial Type
- Treatment
- Last Update
- 3 months ago
- SparkCures ID
- 1492
- NCT Identifier
- NCT03150004
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.